RNA has been at the center of medical innovation in recent years, powering breakthroughs in vaccines and therapeutics. However traditional linear messenger RNA (mRNA) comes with well-known limitations: short-lived protein production, cold-chain storage requirements, and multiple dosing schedules that complicate patient compliance.
A new solution is emerging—circular RNA (circRNA). Unlike linear mRNA, circRNA forms a closed loop, unlocking advantages in stability, durability, and performance that position it as a next-generation platform for medicine.
At Circurna, we’ve built our proprietary ciRNA™ platform around these advantages, pioneering therapies and vaccines designed for global impact.
What is Circular RNA?
Circular RNA is exactly what its name suggests: an RNA molecule in the shape of a closed loop. By eliminating free ends, circRNA avoids the rapid degradation that plagues linear mRNA. This simple but powerful structural difference leads to:
- Increased stability in cells
- More consistent and durable protein expression
- Greater efficiency per dose
While mRNA breaks down quickly in the body, circRNA continues to produce proteins for extended periods, translating into stronger and more reliable therapeutic effects.
Why Circular RNA is a Breakthrough
1. Enhanced Durability
CircRNA can remain active in cells up to 10x longer than mRNA. That means lower frequency dosing than traditional mRNA treatments.
2. Improved Patient Compliance
Fewer doses, combined with microneedle patch delivery (a technology exclusively licensed to Circurna for circular RNA), make circRNA therapies easier and more comfortable for patients. As compared with intramuscular injections, a patch applied to the skin can deliver the therapy painlessly in seconds.
3. No Cold Chain Requirement
Circurna’s ciRNA™ technology has demonstrated stability at room temperature. By removing the need for expensive refrigeration or ultra-cold freezers, circRNA expands access globally and lowers logistical barriers for large-scale deployment.
4. High-Purity Manufacturing
Our proprietary purification method achieves 85–95% purity—significantly higher than conventional methods. This ensures safety, consistency, and scalability for both vaccines and therapeutics.
5. Versatile Applications
CircRNA is not limited to a single therapeutic area. Its flexibility enables:
- Vaccines against emerging infectious diseases and solid tumors.
- Oncology treatments, such as targeted cancer immunotherapies and cell therapies.
- Autoimmune therapies to modulate and reprogram immune responses.
- Protein therapeutics (antibodies, peptides, and multi-payload constructs).
The Circurna Advantage
Circurna is uniquely positioned to lead the circular RNA field with our integrated ciRNA™ platform:
- Exclusive Microneedle Patch Rights: Painless, compliance-friendly delivery of ciRNA™.
- AI-Enhanced Development: Through our partnership with GATC Health, we apply machine learning to lipid nanoparticle design, ligand targeting, and neoantigen sequence optimization—accelerating development cycles and improving outcomes.
- Strong Global Partnerships: Backed by CEPI, NIH, and leading research collaborators worldwide.
- Broad Vision: While many competitors have a pipeline largely defined by a single target (CD19), Circurna is advancing a broader high value pipeline to address fibrosis, cancer, and autoimmune disorders.
Why It Matters Now
The world needs therapies that are faster to develop, easier to distribute, and more durable. Circular RNA directly addresses these needs:
- It enables rapid-response vaccines against emerging pathogens.
- It provides long-lasting protein expression for cancer, fibrosis and autoimmune disorders.
- It reduces the logistical burden of cold-chain storage, making therapies more accessible worldwide.
With these advantages, circRNA is set to become a cornerstone of the next generation of medicine.
More than just a slight step forward…
Circular RNA is more than just an incremental improvement over mRNA—it’s a transformational leap forward in RNA science. With its unique combination of stability, durability, and versatility, circRNA has the potential to reshape how we prevent and treat disease.
At Circurna, our mission is clear: to unlock the full potential of circRNA for a healthier, more resilient future.